Default: Current Opinion in Biotechnology

ISSN: 0958-1669

Journal Home

Journal Guideline

Current Opinion in Biotechnology Q1 Unclaimed

Elsevier Ltd. Netherlands
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Current Opinion in Biotechnology is a journal indexed in SJR in Biotechnology and Bioengineering with an H index of 192. It has a price of 2100 €. It has an SJR impact factor of 2,819 and it has a best quartile of Q1. It is published in English.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Price

2100 €

Gold OA

-

Green OA

0 €

Non OA

Metrics

Current Opinion in Biotechnology

2,819

SJR Impact factor

192

H Index

167

Total Docs (Last Year)

469

Total Docs (3 years)

10335

Total Refs

4049

Total Cites (3 years)

435

Citable Docs (3 years)

8,84

Cites/Doc (2 years)

61,89

Ref/Doc


Best articles

Advances in mass spectrometry for proteome analysis

View more

Analysis of the plant proteome

View more

Antiangiogenic agents

View more

Bioprocessing of therapeutic proteins

View more

Biotechnology

View more

Biotechnology Paper alert

View more

Biotechnology Paper alert

View more

BiotechnologyPaper alert

View more

Computational methods for gene annotation: the Arabidopsis genome

View more

Current and emerging technologies for the study of bacteria in the outdoor air

View more

Differences among mechanisms of ribozyme-catalyzed reactions

View more

Engineered liver for transplantation

View more
SHOW MORE ARTICLES

Engineering the mouse genome by site-specific recombination

View more

Expression vectors and delivery systems Food biotechnology

View more

Extraction of pharmacophore information from high-throughput screens

View more

Fermentation technologies for the production of probiotics with high viability and functionality

View more

Food biotechnology

View more

For better health and nutrition

View more

Forest tree biotechnology

View more

High-throughput screening of enzyme libraries

View more

Homology-independent protein engineering

View more

Implications of sequencing bacterial genomes for pathogenesis and vaccine development

View more

Ligand-binding domain of estrogen receptors

View more

Light at the end of the tunnel: from genes to function

View more

Comments

No comments ... Be the first to comment!